Do or die for TXMD. Waiting on the outcome of the FDA meeting minutes. The general due date is sometime today which is 30 days since the meeting. Most figure a black box label will be required until a phase 4 clinical 12 month study is submitted. Only a 30 day study was presented on endometrial reaction which had no reaction and had followed the guidelines of the FDA, but the FDA initially objected because of that reason.
TXMD holding on my pocket change play as previously posted.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.